Multifocal tDCS in patients with Parkinson's Disease

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00026640

Enrollment

Registered

2021-09-20

Start date

2021-09-21

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G20

Interventions

Group 1: 20 min network targeted multifocal tDCS Group 2: 20 min sham stimulation

Eligibility

Sex/Gender

All

Age

40 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patients with Parkinson's disease, age 40-70 years, informed consent

Exclusion criteria

Exclusion criteria: Pronounced concomitant psychiatric symptoms (dementia symptoms, affective disorder), metal implants in the head, pacemaker, acute eczema of the scalp, known epilepsy, pregnancy, sensorineural hearing prosthesis, marked limitations of cognitive functions and verbal utterance

Design outcomes

Primary

Measure	Time frame
Changes in UPDRS-III as well as amplitude and velocity of diadochokinesis. Values will be compared to measurements on day of sham stimulation.	—

Secondary

Measure	Time frame
Subjective perception of the patients about the effect of the stimulation written in a scale (0-10)	—

Countries

Germany

Contacts

Public ContactLukas Goede

Charité Campus Charité Mitte

lukas.goede@charite.de+4930450660543

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026